Document Detail


Nitric oxide and angiotensin II regulate cardiovascular homeostasis and the arterial baroreflex control of heart rate in conscious lambs.
MedLine Citation:
PMID:  21987534     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To investigate the potential role of angiotensin II (Ang II) type 1 receptors (AT(1)Rs) as well as endogenously produced nitric oxide (NO) in regulating cardiovascular homeostasis during ontogeny, experiments were carried out in conscious lambs aged approximately 1 week (N = 9) and 6 weeks (N = 11). The arterial baroreflex control of heart rate (HR) was assessed before and after intravenous (IV) infusion of the selective AT(1)R antagonist, ZD 7155, before and after IV administration of the L-arginine analogue, N(G)-nitro-L-arginine methyl ester (L-NAME). In both groups, after ZD 7155 alone, mean arterial pressure decreased then increased after L-NAME. At 1 but not 6 weeks, HR decreased after ZD 7155 as well as after L-NAME. At 1 but not 6 weeks, there was a decrease in the HR range after ZD 7155 and after ZD 7155 + L-NAME, as compared to control. There was also a decrease in minimum HR after ZD 7155 + L-NAME at 1 week. These data provide new evidence that, together, Ang II and NO regulate cardiovascular homeostasis as well as the arterial baroreflex of HR early in life which may help to explain the activation of these two systems early in life.
Authors:
Stephanie J Wehlage; Francine G Smith
Related Documents :
7839394 - Carotid intima-media thickness and plaque in borderline hypertension.
3677144 - Enhanced vagal activity and normal arginine vasopressin response in carotid sinus syndr...
6208794 - Blood volume changes and high and low pressoreceptor activity in cats.
1860324 - Aortic-carotid artery pressure differences and cephalic perfusion pressure during cardi...
1839824 - Epidemiology of hypertension and hypertensive target-organ damage in the united states.
17145464 - The mitchell and scarf osteotomies for hallux valgus correction: a retrospective, compa...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-10-10
Journal Detail:
Title:  Journal of the renin-angiotensin-aldosterone system : JRAAS     Volume:  13     ISSN:  1752-8976     ISO Abbreviation:  J Renin Angiotensin Aldosterone Syst     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-03-05     Completed Date:  2012-06-27     Revised Date:  2013-05-03    
Medline Journal Info:
Nlm Unique ID:  100971636     Medline TA:  J Renin Angiotensin Aldosterone Syst     Country:  England    
Other Details:
Languages:  eng     Pagination:  99-106     Citation Subset:  IM    
Affiliation:
Alberta Children's Hospital Research Institute for Child and Maternal Health, University of Calgary, Calgary, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II / pharmacology*
Animals
Arteries / drug effects,  physiology*
Baroreflex / drug effects*
Consciousness / drug effects*
Female
Heart Rate / drug effects*
Homeostasis / drug effects*
Kidney / blood supply,  drug effects
Male
NG-Nitroarginine Methyl Ester / pharmacology
Naphthyridines / pharmacology
Nitric Oxide / pharmacology*
Regional Blood Flow / drug effects
Sheep, Domestic / physiology
Vascular Resistance / drug effects
Grant Support
ID/Acronym/Agency:
14082-1//Canadian Institutes of Health Research
Chemical
Reg. No./Substance:
0/Naphthyridines; 0/ZD 7155; 10102-43-9/Nitric Oxide; 11128-99-7/Angiotensin II; 50903-99-6/NG-Nitroarginine Methyl Ester

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and redu...
Next Document:  Haemodynamic effects of aliskiren in decompensated severe heart failure.